Published in Neurology on April 08, 2003
Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am (2010) 1.53
Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature. Medicine (Baltimore) (2015) 0.88
Cerebral venous thrombosis in the mediterranean area in children. Mediterr J Hematol Infect Dis (2011) 0.85
Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study. J Neurol Neurosurg Psychiatry (2006) 0.85
Pediatric stroke. Childs Nerv Syst (2011) 0.84
Recurrent Cerebral Venous Thrombosis Associated with Elevated Factor VIII. J Clin Neurol (2006) 0.77
Impact of Provoking Risk Factors on the Prognosis of Cerebral Venous Thrombosis in Korean Patients. J Stroke (2016) 0.75
Cerebral Sinus and Venous Thrombosis Associated with von Willebrand Factor, Independently of Factor VIII. Clin Med Case Rep (2008) 0.75
Evaluation of cases with cerebral thrombosis in children. Turk Pediatri Ars (2016) 0.75
Functional outcome after severe cerebral venous thrombosis. J Neurol (2007) 0.75
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (1996) 11.59
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Relapses and progression of disability in multiple sclerosis. N Engl J Med (2000) 4.17
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet (1997) 3.11
Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol (1999) 2.67
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke (1999) 2.28
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science (1992) 2.24
Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing. Arch Neurol (1988) 2.23
Severe pathological crying after left anterior choroidal artery infarct. Reversibility with paroxetine treatment. Stroke (1997) 2.07
The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol (2000) 2.04
Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol (1999) 2.02
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
[Dysplasia of the femoral trochlea]. Rev Chir Orthop Reparatrice Appar Mot (1990) 1.86
Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke (2002) 1.82
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain (2004) 1.59
Confirmation of linkage of Friedreich ataxia to chromosome 9 and identification of a new closely linked marker. Genomics (1989) 1.59
Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol (1996) 1.56
Hyperbaric oxygen in the treatment of acute ischemic stroke: an unsettled issue. J Neurol Sci (1997) 1.55
[Genetic study of mucoviscidosis (a personal statistical survey of 273 families)]. Arch Fr Pediatr (1971) 1.47
Pontine versus capsular pure motor hemiparesis. Neurology (1993) 1.47
Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry (2008) 1.46
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry (1997) 1.44
Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.44
Should we inhibit gastric acid secretion before cardiac surgery? Anesth Analg (1990) 1.42
Accuracy of three-dimensional gadolinium-enhanced MR angiography in the assessment of extracranial carotid artery disease. AJR Am J Roentgenol (2000) 1.42
[Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French Society of Neurovascular Disorders]. Rev Neurol (Paris) (2000) 1.39
Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr (1986) 1.29
The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis (1998) 1.29
Functional anatomy of perceptual and semantic processing for odors. J Cogn Neurosci (1999) 1.29
Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging (1996) 1.25
A comparative study of medial versus lateral arthroscopic partial meniscectomy on stable knees: 10-year minimum follow-up. Arthroscopy (2003) 1.21
Central nervous system cavernomas in the pediatric age group. Neurosurg Rev (2001) 1.19
Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol (2002) 1.16
Intraocular foreign bodies. Factors influencing final visual outcome. Acta Ophthalmol Scand (1999) 1.15
Transient neurologic symptoms related to cerebral amyloid angiopathy: usefulness of T2*-weighted imaging. Cerebrovasc Dis (2004) 1.13
Dissociation of temporal and frontal components in the human auditory N1 wave: a scalp current density and dipole model analysis. Electroencephalogr Clin Neurophysiol (1994) 1.12
Early detection of cerebral arterial occlusion on magnetic resonance angiography: predictive value of the baseline NIHSS score and impact on neurological outcome. Cerebrovasc Dis (2002) 1.10
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08
Carcino-fetal antigen in glial tumours. Lancet (1971) 1.08
[Management of malignant gliomas diagnosed during pregnancy]. Rev Neurol (Paris) (2006) 1.05
Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke (1995) 1.04
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology (1996) 1.03
Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res (2002) 1.03
Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology. Dig Dis Sci (1999) 1.02
Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry (2005) 1.01
Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke (2003) 1.01
Activation of a distributed somatosensory cortical network in the human brain. A dipole modelling study of magnetic fields evoked by median nerve stimulation. Part I: Location and activation timing of SEF sources. Electroencephalogr Clin Neurophysiol (1997) 1.00
The natural history of the knee following arthroscopic medial meniscectomy. Knee Surg Sports Traumatol Arthrosc (2001) 1.00
Separate neural substrates in the human cerebellum for sensory-motor adaptation of reactive and of scanning voluntary saccades. Cerebellum (2008) 0.99
Allodynia after lateral-medullary (Wallenberg) infarct. A PET study. Brain (1998) 0.99
Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus. Neurology (2001) 0.98
Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain (1998) 0.98
Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Dis Assoc Disord (1996) 0.98
[Nephropathies in progressive lipodystrophy or Barraquer-Simons disease]. Ann Pediatr (Paris) (1965) 0.98
[Imaging of osteoarticular tuberculosis]. J Radiol (2002) 0.98
[Pure (dynamic ?) agraphia of frontal origin. Apropos of one case]. Rev Neurol (Paris) (1975) 0.98
[Lambl's excrescence: an uncommon cause of cerebral embolism]. Rev Neurol (Paris) (1995) 0.97
Hypointense leptomeningeal vessels at T2*-weighted MRI in acute ischemic stroke. Neurology (2005) 0.97
[Effect of age on the natural history of the shoulder: a clinical and radiological study in the elderly]. Rev Chir Orthop Reparatrice Appar Mot (2005) 0.97
Evidence for interacting cortical control of vestibular function and spatial representation in man. Neuropsychologia (2003) 0.97
Giant lambl excrescences. An unusual source of cerebral embolism. Arch Neurol (1997) 0.96
Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum (1998) 0.96
Brain stem diffusion-weighted imaging lesion score: a potential marker of outcome in acute basilar artery occlusion. AJNR Am J Neuroradiol (2008) 0.96